Best Healthcare Companies in Oxford, United Kingdom
The 43 best Healthcare companies in Oxford, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Pepgen.
Ranked: Best Healthcare companies in Oxford
| # | Company | Last round | Disclosed funding | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Acquirecare Provider of in-home care services, including hourly and live-in assistance | — | — | — | — | WordPressMySQLPHP+21 | Top 10M | — | — |
| 2 | Caudex Provider of medical communications services for pharmaceutical companies | — | — | 177 | James Karcher CEO | — | — | — | — |
| 3 | Consultant Connect Foundation focused on providing of healthcare communication and telemedicine network | — | — | 28 28 → 48 (+71%) | Jonathan Patrick CEO | WordPressMySQLPHP+22 | Top 5M | — | 1 award |
| 4 | Cortex Organics Provider of synthetic chemistry services primarily to the pharmaceutical and life sciences industries | — | — | 1 | Darren Dixon Co-Founder & CSO | — | — | — | — |
| 5 | Dark Blue Therapeutics Biotechnology company focused on drugs discovery services | — | — | 12 | — | — | — | — | — |
| 6 | Elite Surgitech Manufacturer of a wide range of surgical tools | — | — | — | Mohammed Abbas CEO & Director | — | — | — | — |
| 7 | EPoC Science Provider of neurology-focused drug development services | — | — | — | Hiromasa Mori Founder | — | — | — | — |
| 8 | Healthcare Research Worldwide Provider of market research services | — | — | 86 | — | — | — | — | — |
Top 12 Healthcare companies in Oxford
#1
Public · Oxford, England · founded 1995 · 815 employees$149.7Mraised▾
Manufacturer of viral vectors for cell and gene therapy products. Services include process development, analytical methods, and manufacturing support for advanced therapy developers. Expertise spans lentivirus, adeno-associated virus, and adenovirus platforms to facilitate the development and production of therapeutic treatments.
- Aug 2025Post IPO$81.3M
- Jan 2025Post IPO—
- Sep 2021Post IPO$68.3M
- Apr 2019Unattributed—
#2
Public · Oxford, England · founded 2018 · 54 employees$157.5Mraised▾
Pepgen provides various biopharmaceutical therapies. The company develops novel autoimmune, inflammatory, and viral therapies. The company also developed the next generation of short peptides that attach to antisense oligonucleotides to improve the delivery to muscles.
- Jul 2021Series B$112.5M
- Nov 2020Series A$45M
- Jan 2020Grant (prize money)$69.9K
#3
Seed · Oxford, England · founded 2020 · 5 employees$1.5Mraised▾
Internet-first brand offering plant-based nutritional supplements. It offers BACX performance fuel for fitness enthusiasts that helps in fat metabolism and improves muscle function.
- Oct 2023Seed$1M
- Dec 2022Seed$1.7M
- Apr 2021Seed$382.4K
#4
Series B · Oxford, England · founded 2009 · 4 employees$16.2Mraised▾
Chronos Therapeutic is a drug discovery and development company focusing on - Repositioning FDA approved drugs, screening, discovery and development of novel proprietary drug candidates. Targets include diseases of ageing: Osteoporosis, Cancer and Sarcopenia. Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, ALS and Orphan Synucleopathies. Claim that the research is successfully advancing from pre-clinical stages of development for age-related disease treatments to clinical development. The drug discovery and development platform - Chronoscreen has enabled the company to quickly gain proprietary positions in the regulation of cellular chronological lifespan.
- Nov 2014Grant (prize money)$8.2K
- Dec 2013Series B$13M
- Oct 2012Series A$3.2M
#5
Acquired · Oxford, England · founded 2011 · 14 employees$8.2Mraised▾
Cerus Endovascular is engaged in the design and development of highly differentiated and proprietary interventional neuroradiology (INR) devices and delivery systems. These devices will have applications in the minimally invasive treatment of neurovascular diseases, particularly intracranial aneurysms.
- Aug 2019Series A$5.9M
- Jun 2013Seed$2.3M
#6
Seed · Oxford, England · founded 2019 · 1 employees$1.2Mraised▾
Provider of healthcare information services
- Dec 2022Seed$1.2M
#7
Acquired · Oxford, England · founded 1943 · 141 employees$7.1Mraised▾
Manufacturer of anesthesia and respiratory medical devices. It develops, manufactures, and distributes products for airway management, anesthesia delivery, oxygen therapy, and suction systems. The company offers a range of products including anesthetic machines, patient monitors, and laryngoscopes, designed for use in various clinical settings, including MRI environments. Its products are known for intuitive user interfaces and focus on patient safety.
#8
Deadpooled · Oxford, England · founded 2016$2.6Mraised▾
Oxford Impedance Diagnostics is a spin-off company of Oxford University focused on developing a point-of-care platform for early and precise disease diagnosis. The company's diagnostic platform is based on micro electrical impedance technology and is developed by Professor Jason Davis (Oxford University) and Professor Paulo Bueno (Sao Paulo State University, Brazil). It is working in collaboration with other companies and universities to develop new diagnostic tests or to improve the sensitivity of the existing tests. In addition, the company is primarily focused on the development of three of its own assays for Parkinson’s disease, breast cancer, and dengue fever.
- Jul 2016Seed$2.6M
#9
Seed · Oxford, England · founded 2005 · 8 employees$850.4Kraised▾
Provider of vitro blood test device
- May 2019Seed$330K
- Mar 2019Seed$262.6K
- Jun 2017Seed$257.8K
#10
Funding Raised · Oxford, England · founded 1996 · 4954 employees$328.2Kraised▾
Oxford University Hospitals is a network of multispeciality hospitals. Offers specialities such as Audiology, cleft lip and palate, craniofacial surgery, ENT, oral and maxillofacial surgery, orthodontics, cardiothoracic, pathology, dermatology, endocrinology, genetics, geratology, gynecology, neurology, oncology, orthopedics, podiatry, urology and ophthalmology.
- Mar 2021Grant (prize money)$328.2K
#11
Seed · Oxford, England · founded 2012 · 6 employees$215Kraised▾
Developer of 3D motion analysis technology designed to offer a reliable approach to the treatment of injuries and improve performance. The company's technology automatically extracts musculoskeletal injury risk factors and gait retaining parameters from the 3D joint kinematics, compares them to the database of uninjured controls, and presents them in an easy-to-interpret graphical format, enabling runners to get treatment for a wide range of orthopedic and musculoskeletal problems using specialized and evidence-based gait retraining procedures.
- Mar 2019Seed$13.2K
- Oct 2017Seed—
- Dec 2013Seed$40.9K
- Dec 2012Seed$160.9K
#12
Series A · Oxford, England · founded 2006 · 30 employees$270.5Kraised▾
Oxford Expression Technologies develops reagents for protein expression and cell culture. The product line of the company includes BaculoVirus system based products, Insect cell culture products and, Recombinant proteins. Additionally, the company also provides services in Mammalian cell protein expression, Baculovirus services, and Insect Cell Baculovirus Expression and Recombinant Protein Production.
- Nov 2016Grant (prize money)$270.5K
- Dec 2008Series A—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.